Clinical trial Recruiting at 1 site Interventional Ages 50 to 64

Effects of a Western Diet on Heart and Immune Health

Official title: Effects of a 10-day Western Diet on Cardiometabolic and Immune Function in Midlife Adults

Run by University of Delaware · NCT06528977 · Data updated 2026-11-12

This study is testing how a Western diet high in added sugars affects heart health and immune function in middle-aged adults.

More Aging trials

Quick facts

Study typeInterventional
Ages50 Years to 64 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of Delaware
Academic / other
Locations1 site (Newark, Delaware)
StatusRecruiting
StartedJuly 17, 2024
Main results expectedJuly 2026
Study endsJuly 2027
Registry record updatedJuly 30, 2024
Trial IDNCT06528977 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men and postmenopausal women aged 50-64 with specific health metrics indicating stable cardiovascular health.

Probably not a fit

Patients with chronic diseases or those currently taking medications that affect triglycerides or cholesterol may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of a Western Diet on cardiometabolic and immune function in middle-aged adults aged 50 to 64 years. Participants will follow a 10-day diet consisting of 25% of total energy from added sugars, while researchers will assess vascular health, intestinal permeability, and T-cell function before, during, and after the diet. The goal is to understand how dietary changes influence gut health and immune responses, particularly in relation to aging and cardiovascular health. The findings could provide insights into the relationship between diet and immune system activation.

Why it matters

Potential benefit: If successful, this study could lead to better dietary recommendations that improve cardiometabolic health and immune function in aging populations.

How similar studies have gone: While the specific approach of this study may be novel, previous studies have indicated that dietary interventions can significantly impact cardiometabolic health.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ability to provide informed consent
* men and postmenopausal women aged 50-64 years
* systolic blood pressure \< 130 mmHg; diastolic blood pressure \< 90 mmHg
* body mass index (BMI) \<30 kg/m2 and % body fat \< 25% for men and \< 33% for women
* fasting triglycerides \< 200 mg/dl (\< 2.3 mmol/L)
* low density lipoprotein (LDL) cholesterol \<160 mg/dl (4.14 mmol/L)
* fasting plasma glucose \<126 mg/dl (\<7.0 mmol/L)
* weight stable in the prior 6 months (≤ 2 kg weight change)
* blood chemistries indicative of normal liver enzymes and renal function (estimated glomerular filtration rate using the Modification of Diet in Renal Disease (MDRD) prediction equation must be \>60 ml/min/1.73 m\^2)

Exclusion Criteria:

* current use of medications or supplements known to lower blood triglycerides or cholesterol (e.g., fibrates, statins, high dose niacin, high dose omega-3 supplement)
* chronic clinical diseases (e.g., coronary artery/peripheral artery/cerebrovascular diseases, heart failure, diabetes, chronic kidney disease requiring dialysis, neurological or autoimmune conditions affecting cognition (e.g. Alzheimer's disease or other forms of dementia, Parkinson's disease, epilepsy, multiple sclerosis, large vessel infarct)
* major psychiatric disorder (e.g. schizophrenia, bipolar disorder)
* current or past (i.e., last 3 months) use of anti-hypertensive or other cardiovascular-acting medications known to influence vascular function and/or arterial stiffness
* current medication use likely to affect central nervous system (CNS) functions (e.g. long active benzodiazepines)
* concussion within last 2 years and ≥ 3 lifetime concussions
* heavy alcohol consumption (≥8 drinks/week for women and ≥15 drinks/week for men)
* recent major change in health status within the previous 6 months (i.e., surgery, significant infection, or illness)
* current smoking within the past 3 months.

Where it's running

  • University of Delaware
    Newark, Delaware, United States
    Recruiting

Study contacts

  • Principal investigator: Christopher Martens, Ph.D. — University of Delaware
  • Study coordinator: Kevin Decker, Ph.D.
  • Email: Deckerkp@udel.edu
  • Phone: (302) 831-8137

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.